Business Wire

PA-BOOMI

8.5.2024 18:01:35 CEST | Business Wire | Press release

Share
Boomi Unveils New Vision with Strategic Acquisitions and Latest Innovations at Boomi World 2024

Boomi™, the intelligent integration and automation leader, today unveiled its vision for the company’s future, along with strategic acquisitions and key product announcements at Boomi World 2024. With more than 20,000 global customers and a network of approximately 800 partners worldwide, Boomi is leading the industry towards the future with a focus on integration and automation, API management, and data management, all made more important and powerful than ever with the emergence of the AI economy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508488304/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Boomi Unveils New Vision with Strategic Acquisitions and Latest Innovations at Boomi World 2024 (Graphic: Business Wire)

In his keynote, Boomi CEO Steve Lucas emphasized the transformative impact of integration platform as a service (iPaaS), spotlighting its pivotal role in enhancing speed, agility, and effectiveness across business operations. Lucas explained how Boomi’s iPaaS streamlines connectivity — seamlessly linking people, systems, devices, and applications — for building stronger relationships and enabling swift, informed decision-making through real-time data access.

But Boomi recognizes the opportunity to take connectivity even further, and to bring connectivity solutions to more companies in more areas of business and IT.

“Connectivity,” Lucas pointed out, “remains a critical challenge for almost every organization. The chief culprit is digital fragmentation, a byproduct of digital shifts that, paradoxically, lead to digital silos and disjointed technical architectures that leave the average enterprise now juggling over 364 applications and numerous API gateways.”

The emergence of the AI economy has further highlighted the challenges of digital fragmentation. "AI thrives on reliable, secure, and current data, yet too often, this data is fragmented, difficult to govern, and not securely managed," Lucas noted. “What companies urgently need is a unified, enterprise-scale platform that not only bridges APIs, applications, data, and AI models, but also accelerates digital transformation.”

To address these pressing challenges, Boomi unveiled key announcements at Boomi World, including:

New Boomi Enterprise Platform Vision

Boomi has expanded and deepened the capabilities of the Boomi Enterprise Platform with:

  • Next-generation API management for the AI economy
  • An AI agent framework that provides out-of-the-box AI agents, pluggability for 3rd party AI agents, as well as the ability to automate AI orchestration workflows
  • Enhanced data management to support data quality, data lineage, and metadata management

Next-Generation API Management for the AI Economy

Joining Lucas onstage, Matt McLarty, CTO at Boomi, explained that “companies today suffer from API sprawl: API gateways are everywhere, and there’s no effective global view or management dashboard for discovering, governing, and securing them, let alone rationalizing API investments and promoting best-in-class APIs for adoption. The AI economy requires next-generation API management (APIM) that accounts for a fragmented APIM landscape and can handle the demands of enterprise-grade scalability and security that AI workloads place on APIM solutions.”

To solve this problem, Boomi announced the acquisitions of APIIDA’s federated API management business and API management assets from Cloud Software Group. Both acquisitions accelerate Boomi’s roadmap for providing solutions to the most pressing API management challenges that companies face today, allowing enterprises to rapidly and securely deliver business value through API products in one end-to-end enterprise platform.

Boomi AI Agent Framework

To accelerate innovation in the AI economy, Boomi introduced the Boomi AI agent framework, a set of integration and no-code development capabilities that enable business and IT users to run AI agents built by Boomi or Boomi partners, and to build and run their own AI agents to solve pressing integration and automation requirements.

Boomi introduced four new agents built into the platform that make use of the new AI agent framework, including:

  • Boomi Answers: Agent for providing prescriptive help
  • Boomi DataDetective: Agent for classifying data fields, protecting sensitive data like personally identifiable information (PII), and tracking where data is being moved
  • Boomi DesignGen: Agent for autonomously building integrations
  • Boomi Scribe: Agent for automatically documenting existing and built-by-AI integrations

In addition, the Boomi AI agent framework is open to third parties, and supports pluggable AI agents, allowing customers to integrate third-party AI agents into the platform via APIs or Boomi GPT.

In his Boomi World keynote, Lucas announced a strategic OEM agreement with Vianai Systems, a leading provider of conversational AI solutions for finance, and demonstrated one of the first third-party AI agents, Boomi FinTalk powered by Vianai. Customers can seamlessly connect to Boomi FinTalk powered by Vianai via Boomi GPT, leveraging Boomi’s AI agent framework. Using Boomi, the agent connects to sources of financial data in ERP systems, databases, documents, customers’ data lakes, and other data, and enables users to ask questions of their data through a natural language interface to discover and analyze financial data and trends in real-time, for immediate actionable insights.

“Technology and business leaders have struggled to leverage the power of generative AI in their enterprises due to the very real issues of accuracy and security, relevance to business users with domain-specific requirements, and the inability to query both structured and unstructured data and systems in natural language,” said Dr. Vishal Sikka, Founder and CEO, Vianai Systems. “With Boomi FinTalk powered by Vianai, we are solving these issues with Boomi’s vast integration capabilities and Vianai’s conversational AI application for CFOs and finance users, enabling real-time, accurate, and actionable insights to drive business transformation.”

Trusted Data Management

Boomi also announced Boomi DataHub, a trusted data foundation for operational, analytical, and AI workloads. A high velocity, high quality data access layer, Boomi DataHub provides master data management, integration pipelines, and a framework that will expand over time to provide other data management capabilities, including enterprise scale movement and standardization of data for AI and analytics initiatives.

“Centralizing data has proved to be a dead end for companies,” said Lucas. “A better approach is to build connectivity, governance, and automation into the IT resources companies already have, taking advantage of AI to make this work faster and easier than ever before. With the Boomi Enterprise Platform, we’re giving customers the foundation they need for connecting and managing all their data, and for accelerating AI and API development. Using Boomi, customers can say goodbye to the digital fragmentation that’s been undermining their digital transformation efforts, and finally get the comprehensive visibility, control, and automation they need.”

Check out all the latest announcements from Boomi World 2024 here.

Additional Resources

About Boomi

Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com

© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508488304/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer House of Code for at styrke teknologi- og dataløsninger26.6.2026 20:01:00 CEST | Pressemeddelelse

Andersen Consulting forstærker sine kompetencer inden for teknologisk transformation gennem en samarbejdsaftale med House of Code, en global virksomhed med hovedkvarter i USA, der specialiserer sig i datadrevne platforme, automatisering og agentbaserede ai-løsninger. House of Code blev stiftet i 2001 og udvikler softwareløsninger samt yder rådgivning til energihandels- og finanssektoren med kunder, der spænder over hedgefonde, kapitalfonde og forsyningsvirksomheder. Virksomheden besidder dyb ekspertise inden for energihandel og risikostyring og hjælper organisationer med systemimplementering, forretningstransformation, dataautomatisering og ai-underbygget modernisering af arbejdsgange. Deres proprietære platform, Enterprise Platform for Integrated Compliance (EPIC), skaber en mere effektiv datastyring, automatiserer rapporteringsprocesser, forbedrer den driftsmæssige gennemsigtighed på tværs af virksomhedssystemer og skaber et fundament for opbygning af intelligente, agentbaserede arbe

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press release

Receives AI Governance & Risk Excellence Award at OpenAI Partner SummitCapco’s UK AI Lab wins OpenAI Codex Hackathon Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solutio

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye